SOURCE: EndoChoice


May 09, 2011 06:00 ET

New EndoChoice Products Revolutionize GI Practices

giDash™, giComply™ Leverage Technology to Provide Analysis & Accuracy for GI Professionals

CHICAGO, IL--(Marketwire - May 9, 2011) - EndoChoice, Inc. announced today the launch of two revolutionary products that help the gastroenterologist manage their practice through dynamic dashboard providing metrics and better accuracy with an electronic pathology requisition and logbook.

EndoChoice's giDash™ provides key physician metrics in real time and trending formats to help monitor and drive practice profitability. The feature-rich giDash program incorporates a dashboard populated with key metrics that are visually displayed for at-a-glance review. Physicians can also view data that includes financial-payer mix, collections, aging, referrals and productivity. Already in use by 2,400+ physicians nationwide, giDash has been specifically tailored to meet the unique needs of GI practices.

The company will also debut giComply™, a software program that automates the traditional pathology logbook and generates fast, accurate requisitions and labels. With giComply, the nurse selects a patient from the practice management system; enters specimen information using intuitive, onscreen anatomic graphics and drop-down menus; then prints the requisition and labels. All information is automatically entered into the electronic logbook, which includes a searchable database and the ability to color-code entries for faster, easier reference.

"Looking at the challenges facing Gastroenterology today, we were inspired to create technology solutions that help GI and endoscopy practices operate more efficiently," says Mark Gilreath, the chief executive officer and founder of EndoChoice. "Our insight into the industry, and input from our customers, led us to create giDash and giComply."

About EndoChoice
EndoChoice is a global leader and medical technology provider for specialists treating a wide range of gastrointestinal diseases. EndoChoice is committed to the GI endoscopy market offering a comprehensive portfolio of treatment options for tissue acquisition, anatomic pathology, hemostasis, luminal patency, retrieval, infection control and procedural support. For more information, visit

Contact Information

  • Contact:
    Scott Fraser
    Vice President of Marketing
    Email Contact